Monoclonal antibody directed against CD68, which can aid diagnosis of monocytic leukaemia’s and histiocytic neoplasms and help identify macrophages in tissues from various inflammatory and neoplastic disease states.
| Inventor | Institute |
|---|---|
| Jacqueline Cordell | University of Oxford |
| Cat. #: | 151370 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology;Immunology;Stem cell biology |
| Application: | FACS ; IHC ; IF ; WB |
| Target: | CD68 |
| Reactivity: | Human |
| Clone: | Y1/82A |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | CD68 Molecule; CD68 Antigen; Macrophage Antigen CD68; GP11; Scavenger Receptor Class D; Member; Scavenger Receptor Class D; SCARD1; LAMP4 |
|---|---|
| Product description: | Monoclonal antibody directed against CD68, which can aid diagnosis of monocytic leukaemia's and histiocytic neoplasms and help identify macrophages in tissues from various inflammatory and neoplastic disease states. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Immunogen: | Lysosomal contents of lung macrophages |
| Immunogen Uniprot ID: | P34810 |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | CD68 is a 110 kD glycoprotein, also known as macrosialin, belonging to the sialomucin family. It is closely related to the family of acidic, highly glycosylated lysosomal-associated membrane proteins (LAMPs). CD68 is predominately expressed in cytoplasmic granules of monocytes/macrophages, dendritic cells, and granulocytes. It is one of the useful myeloid cell markers. Further studies have shown that CD68 is also expressed by a subset of hematopoietic progenitors, ?/d T cells, NK cells, LAK cells, subset of B cells, fibroblasts, and endothelial cells. The biological function of CD68 is still unknown. Anti-CD68 (Y1/82A) reacted with peripheral blood and bone marrow monocytes and resident macrophages in all tissues tested. Anti-CD68 did not react with other cell types, apart from some osteoclasts and megakaryocytes. This antibody was shown to be useful in characterising monocytic leukaemia's, histiocytic neoplasms and detecting macrophages in disease. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | Store at -20° C frozen. Avoid repeated freeze / thaw cycles |
| Shipping conditions: | Dry ice |
| References: |
Shenoy et al. 2019. Microbiome. 7(1):37. PMID: 30857553. Lee et al. 2018. Sci Rep. 8(1):15076. PMID: 30305672. Matossian et al. 2018. Breast Cancer Res Treat. 169(2):381-390. PMID: 29392581. Ferguson et al. 2018. Front Immunol. 9:1802. PMID: 30127787. Ferguson et al. 2018. Front Immunol. 9:1802. PMID: 30127787. MacParland et al. 2017. ACS Nano. :. PMID: 28040885. Phenotype Determines Nanoparticle Uptake by Human Macrophages from Liver and Blood. Conrad et al. 2015. Arthritis Res Ther. 17:179. PMID: 26178906. In vivo pre-activation of monocytes in patients with axial spondyloarthritis. Caete et al. 2015. Arthritis Res Ther. 17:173. PMID: 26156866. Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Doussis et al. 1993. J Clin Pathol. 46(4):334-6. PMID: 7684403. CD68 reactivity of non-macrophage derived tumours in cytological specimens. Pulford et al. 1990. Int Immunol. 2(10):973-80. PMID: 2078523. Distribution of the CD68 macrophage/myeloid associated antigen. Micklem et al. 1989. Br J Haematol. 73(1):6-11. PMID: 2803980. A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies. Pulford et al. 1989. J Clin Pathol. 42(4):414-21. PMID: 2654191. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.